This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massaad, C. Articles by Barouki, R. Search for Related Content PubMed PubMed Citation Articles by Massaad, C. Articles by Barouki, R.

Modulation of Human Mineralocorticoid Receptor Function by Protein Kinase A

INSERM Unité 490 (C.M., R.B.) Centre universitaire des Saints-Pères 75270 Paris Cedex 06, France
INSERM Unité 478 (N.H., M.L.) Faculté de Médecine Xavier Bichat 75018 Paris France

The mineralocorticoid receptor (MR) acts as a ligand-dependent transcription factor modulating specific gene expression in sodium-transporting epithelia. Physiological evidence suggest a cross-talk between the cAMP- and aldosterone-signaling pathways. We provide evidence that protein kinase A (PKA), a major mediator of signal transduction pathways, modulates transcriptional activity of the human MR (hMR). Using transient transfection assays in HepG2 cells, we show that 8-bromo-cAMP, a protein kinase A activator, stimulates glucocorticoid response element (GRE)-containing promoters in a ligand-independent manner. This effect was strictly MR dependent since no activation of the reporter gene was observed in the absence of cotransfected hMR expression plasmid. Furthermore, a synergistic activation was achieved when cells were treated with both aldosterone and cAMP. This synergistic effect was also observed in the CV1 and the stable hMR-expressing M cells but was dependent on the promoter used. In particular, synergism was less pronounced in promoters containing several GREs. We show that (protein kinase-inhibiting peptide (PKI), the peptide inhibitor of PKA, prevented both cAMP and aldosterone induction, which indicates that a functional cAMP pathway is required for stimulation of transcription by aldosterone. Using MR-enriched baculovirus extracts in gel shift assays, we have shown that the binding of the MR to a GRE-containing oligonucleotide was enhanced by PKA. Increased DNA binding of hMR is likely to reflect an increase in the number of active receptors, as measured by Scatchard analysis. Using a truncated MR, we show that the N-terminal domain is required for the effect. Finally, the N-terminal truncated MR was not directly phosphorylated by PKA in vitro. We conclude that PKA acts indirectly, probably by relieving the effect of an MR repressor.

This article has been cited by other articles:

				M. Nishi and M. Kawata Brain Corticosteroid Receptor Dynamics and Trafficking: Implications from Live Cell Imaging Neuroscientist, April 1, 2006; 12(2): 119 - 133. [Abstract] [PDF]

				L. Pascual-Le Tallec and M. Lombes The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221. [Abstract] [Full Text] [PDF]

				P. M. Snyder, D. R. Olson, R. Kabra, R. Zhou, and J. C. Steines cAMP and Serum and Glucocorticoid-inducible Kinase (SGK) Regulate the Epithelial Na+ Channel through Convergent Phosphorylation of Nedd4-2 J. Biol. Chem., October 29, 2004; 279(44): 45753 - 45758. [Abstract] [Full Text] [PDF]

				N. Marissal-Arvy, M. Lombes, J. Petterson, M.-P. Moisan, and P. Mormede Gain of Function Mutation in the Mineralocorticoid Receptor of the Brown Norway Rat J. Biol. Chem., September 17, 2004; 279(38): 39232 - 39239. [Abstract] [Full Text] [PDF]

				P. Sartorato, F. Cluzeaud, J. Fagart, S. Viengchareun, M. Lombes, and M.-C. Zennaro New Naturally Occurring Missense Mutations of the Human Mineralocorticoid Receptor Disclose Important Residues Involved in Dynamic Interactions with Deoxyribonucleic Acid, Intracellular Trafficking, and Ligand Binding Mol. Endocrinol., September 1, 2004; 18(9): 2151 - 2165. [Abstract] [Full Text] [PDF]

				C. Le Moellic, A. Ouvrard-Pascaud, C. Capurro, F. Cluzeaud, M. Fay, F. Jaisser, N. Farman, and M. Blot-Chabaud Early Nongenomic Events in Aldosterone Action in Renal Collecting Duct Cells: PKC{alpha} Activation, Mineralocorticoid Receptor Phosphorylation, and Cross-Talk with the Genomic Response J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1145 - 1160. [Abstract] [Full Text] [PDF]

				P. Sartorato, A.-L. Lapeyraque, D. Armanini, U. Kuhnle, Y. Khaldi, R. Salomon, V. Abadie, E. Di Battista, A. Naselli, A. Racine, et al. Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2508 - 2517. [Abstract] [Full Text] [PDF]

				C. E. Deppe, P. J. Heering, S. Viengchareun, B. Grabensee, N. Farman, and M. Lombes Cyclosporine A and FK506 Inhibit Transcriptional Activity of the Human Mineralocorticoid Receptor: A Cell-Based Model to Investigate Partial Aldosterone Resistance in Kidney Transplantation Endocrinology, May 1, 2002; 143(5): 1932 - 1941. [Abstract] [Full Text] [PDF]

				J. D. Stockand New ideas about aldosterone signaling in epithelia Am J Physiol Renal Physiol, April 1, 2002; 282(4): F559 - F576. [Abstract] [Full Text] [PDF]

				R. AEsoy, G. Mellgren, K.-I. Morohashi, and J. Lund Activation of cAMP-Dependent Protein Kinase Increases the Protein Level of Steroidogenic Factor-1 Endocrinology, January 1, 2002; 143(1): 295 - 303. [Abstract] [Full Text] [PDF]

				D. Le Menuet, R. Isnard, M. Bichara, S. Viengchareun, M. Muffat-Joly, F. Walker, M.-C. Zennaro, and M. Lombes Alteration of Cardiac and Renal Functions in Transgenic Mice Overexpressing Human Mineralocorticoid Receptor J. Biol. Chem., October 12, 2001; 276(42): 38911 - 38920. [Abstract] [Full Text] [PDF]

				M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598. [Abstract] [Full Text] [PDF]

				M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF]

				B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730. [Abstract] [Full Text]

				G. Lazennec, L. Canaple, D. Saugy, and W. Wahli Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators Mol. Endocrinol., December 1, 2000; 14(12): 1962 - 1975. [Abstract] [Full Text]

				E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]

				M. D. Sadar and M. E. Gleave Ligand-independent Activation of the Androgen Receptor by the Differentiation Agent Butyrate in Human Prostate Cancer Cells Cancer Res., October 1, 2000; 60(20): 5825 - 5831. [Abstract] [Full Text]

				K. J. Greenland, I. Jantke, S. Jenatschke, K. E. Bracken, C. Vinson, and B. Gellersen The Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Gene Promoter Is Controlled by Ets and Activating Protein-1 Transcription Factors and Progesterone Endocrinology, February 1, 2000; 141(2): 581 - 597. [Abstract] [Full Text] [PDF]

				F. Verrey Early aldosterone action: toward filling the gap between transcription and transport Am J Physiol Renal Physiol, September 1, 1999; 277(3): F319 - F327. [Abstract] [Full Text] [PDF]